Latest Articles

All Latest Articles

150411 Articles

Chris Lange | Mar 16, 2016 at 1:35 PM EDT

Regeneron and Sanofi Plan to Appeal Amgen Patent Verdict

Regeneron Pharmaceuticals saw its shares halted on Wednesday afternoon after a jury ruled in favor of Amgen on a cholesterol…

Evan Comen | Mar 16, 2016 at 1:11 PM EDT

The Least Healthy County in Every State

An enormous amount of time and money is spent keeping Americans healthy. Governments at all levels and individuals invest many…

Chris Lange | Mar 16, 2016 at 12:50 PM EDT

4 More Key FDA Decisions in March

24/7 Wall St. has collected a few more U.S. Food and Drug Administration (FDA) decisions coming up in March.

Paul Ausick | Mar 16, 2016 at 12:35 PM EDT

Private Equity Firm Lends $350 Million to Struggling US Oil Producer

In the first publicly reported transaction of its kind, independent energy producer Clayton Williams Energy announced Tuesday that it has…

Chris Lange | Mar 16, 2016 at 12:05 PM EDT

What to Look for in Adobe Earnings

Adobe Systems is set to report its fiscal first-quarter financial results after the markets close on Thursday.

Jon C. Ogg | Mar 16, 2016 at 11:55 AM EDT

3 Nations Where Negative Interest Rates Are Creating Asset Bubble Risks

Moody's is warning that negative interest rates in Switzerland, Denmark and Sweden are having unintended consequences.

Paul Ausick | Mar 16, 2016 at 11:40 AM EDT

London, Deutsche Börse Agree to Merge

The two largest stock exchange operators in Europe have agreed to combine in a merger that would create an exchange…

Chris Lange | Mar 16, 2016 at 11:35 AM EDT

What to Expect From Aeropostale Earnings

Aeropostale is scheduled to report its fiscal fourth-quarter financial results after the markets close on Thursday.

Paul Ausick | Mar 16, 2016 at 11:25 AM EDT

Charter, Time Warner Deal on Track for FCC OK

The FCC reportedly is about to give the green light to the proposed merger between Charter Communications and Time Warner…

Jon C. Ogg | Mar 16, 2016 at 11:20 AM EDT

Why One Analyst Sees Gilead Worth 66% More

Argus reiterated Gilead Sciences as Buy, but hat really matters here is that Argus has a $150 price target on…

Paul Ausick | Mar 16, 2016 at 11:05 AM EDT

Crude Oil Price Rises as Inventory Growth Slows

U.S. commercial crude inventories increased by more than a million barrels last week, according to the EIA.

Jon C. Ogg | Mar 16, 2016 at 10:55 AM EDT

CPI Again Breaches 2% Inflation, at Least Selectively

Here is where the Fed will have enough ammunition to talk rates higher: the annualized core CPI, sans food and…

Chris Lange | Mar 16, 2016 at 10:45 AM EDT

Bio Blast Pharma Explodes on Positive Results

Bio Blast Pharma was blowing away all the other bulls in Wednesday’s session, with its stock up over 150% on…

Lee Jackson | Mar 16, 2016 at 10:40 AM EDT

Refiners May Be Fully Valued: Deutsche Bank Has Just 3 to Buy Now

So are any refiners still a buy? In a new research report, Deutsche Bank says yes, though not many are…

Chris Lange | Mar 16, 2016 at 10:10 AM EDT

How Analysts Rate Oracle After Earnings

Following Oracle's fiscal third-quarter report, a few analysts have decided to give their two cents on the stock.

1 … 5,563 5,564 5,565 5,566 5,567 … 10,028

Latest Articles

All Latest Articles

Regeneron and Sanofi Plan to Appeal Amgen Patent Verdict

The Least Healthy County in Every State

4 More Key FDA Decisions in March

Private Equity Firm Lends $350 Million to Struggling US Oil Producer

What to Look for in Adobe Earnings

3 Nations Where Negative Interest Rates Are Creating Asset Bubble Risks

London, Deutsche Börse Agree to Merge

What to Expect From Aeropostale Earnings

Charter, Time Warner Deal on Track for FCC OK

Why One Analyst Sees Gilead Worth 66% More

Crude Oil Price Rises as Inventory Growth Slows

CPI Again Breaches 2% Inflation, at Least Selectively

Bio Blast Pharma Explodes on Positive Results

Refiners May Be Fully Valued: Deutsche Bank Has Just 3 to Buy Now

How Analysts Rate Oracle After Earnings

Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today

Up 23% From Its 52-Week Low: 1 Critical Metric That Explains Why I’m Standing Pat on Coca-Cola Stock

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

The 1 Number That Might Make You Change Your Mind About When to Claim Social Security

How to Build $3,000 a Month in Dividend Income to Cover the Average Social Security Check

Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today

Up 23% From Its 52-Week Low: 1 Critical Metric That Explains Why I’m Standing Pat on Coca-Cola Stock

Latest Articles

All Latest Articles

Regeneron and Sanofi Plan to Appeal Amgen Patent Verdict

The Least Healthy County in Every State

4 More Key FDA Decisions in March

Private Equity Firm Lends $350 Million to Struggling US Oil Producer

What to Look for in Adobe Earnings

3 Nations Where Negative Interest Rates Are Creating Asset Bubble Risks

London, Deutsche Börse Agree to Merge

What to Expect From Aeropostale Earnings

Charter, Time Warner Deal on Track for FCC OK

Why One Analyst Sees Gilead Worth 66% More

Crude Oil Price Rises as Inventory Growth Slows

CPI Again Breaches 2% Inflation, at Least Selectively

Bio Blast Pharma Explodes on Positive Results

Refiners May Be Fully Valued: Deutsche Bank Has Just 3 to Buy Now

How Analysts Rate Oracle After Earnings

Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today

Up 23% From Its 52-Week Low: 1 Critical Metric That Explains Why I’m Standing Pat on Coca-Cola Stock

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

Featured Reads

The 1 Number That Might Make You Change Your Mind About When to Claim Social Security

How to Build $3,000 a Month in Dividend Income to Cover the Average Social Security Check